Nishino Koichiro, Umezawa Akihiro
Laboratory of Veterinary Biochemistry and Molecular Biology, Graduate School of Medicine and Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, 1-1 Gakuen-Kibanadai-Nishi, Miyazaki, 889-2192, Japan.
Center for Animal Disease Control, University of Miyazaki, 1-1 Gakuen-Kibanadai-Nishi, Miyazaki, 889-2192, Japan.
Hum Cell. 2016 Jul;29(3):97-100. doi: 10.1007/s13577-016-0139-5. Epub 2016 Apr 15.
Indeed human induced pluripotent stem cells (hiPSCs) are considered to be powerful tools in regenerative medicine. To enable the use of hiPSCs in the field of regenerative medicine, it is necessary to understand the mechanisms of reprogramming during the transformation of somatic cells into hiPSCs. Genome-wide epigenetic modification constitutes a critical event in the generation of iPSCs. In other words, to analyze epigenetic changes in iPSCs means to elucidate reprogramming processes. We have established a large number of hiPSCs derived from various human tissues and have obtained their DNA methylation profiles. Comparison analyses indicated that the epigenetic patterns of various hiPSCs, irrespective of their source tissue, were very similar to one another and were similar to those of human embryonic stem cells (hESCs). However, the profiles of hiPSCs and hESCs exhibited epigenetic differences, which were caused by random aberrant hypermethylation at early passages. Interestingly, continuous passaging of the hiPSCs diminished the differences between DNA methylation profiles of hiPSCs and hESCs. The number of aberrant DNA methylation regions may thus represent a useful epigenetic index for evaluating hiPSCs in the context of therapeutic applications.
事实上,人类诱导多能干细胞(hiPSC)被认为是再生医学中的强大工具。为了在再生医学领域应用hiPSC,有必要了解体细胞转化为hiPSC过程中的重编程机制。全基因组表观遗传修饰是诱导多能干细胞产生过程中的关键事件。换句话说,分析诱导多能干细胞中的表观遗传变化意味着阐明重编程过程。我们已经建立了大量源自各种人类组织的hiPSC,并获得了它们的DNA甲基化图谱。比较分析表明,各种hiPSC的表观遗传模式,无论其来源组织如何,彼此非常相似,并且与人类胚胎干细胞(hESC)的表观遗传模式相似。然而,hiPSC和hESC的图谱表现出表观遗传差异,这是由早期传代时随机异常的高甲基化引起的。有趣的是,hiPSC的连续传代减少了hiPSC和hESC的DNA甲基化图谱之间的差异。因此,异常DNA甲基化区域的数量可能代表了在治疗应用背景下评估hiPSC的有用表观遗传指标。